by Zoe Hogue | Jan 30, 2026 | Blog
Introduction In 2026, global healthcare faces a dual threat.Viral pandemics persist, while antimicrobial resistance (AMR) continues to rise quietly but steadily. Traditional antibiotics are losing effectiveness. Meanwhile, many viral infections still lack...
by Zoe Hogue | Jan 30, 2026 | Blog
Introduction Pain management is undergoing a major transformation in 2026.For decades, treatment relied heavily on opioids and NSAIDs. One carried addiction risks. The other caused gastrointestinal and renal side effects. Peptide therapeutics are now emerging as...
by Zoe Hogue | Jan 30, 2026 | Blog
Introduction The gastrointestinal (GI) tract is one of the body’s most powerful peptide-producing systems.It releases hormones that regulate digestion, nutrient absorption, appetite, and immune response. In 2026, GI peptides are rapidly moving from the research...
by Zoe Hogue | Jan 30, 2026 | Blog
Introduction While much attention has focused on the GLP-1 revolution in weight loss, a quieter transformation is unfolding in cardiology.In 2026, cardiovascular disease remains the leading cause of death worldwide. However, peptide therapeutics are moving far...
by Zoe Hogue | Jan 30, 2026 | Blog
Introduction For decades, the central nervous system (CNS) represented the final frontier of pharmaceutical treatment.Diseases such as Alzheimer’s, Parkinson’s, and Amyotrophic Lateral Sclerosis (ALS) remained difficult to treat due to one major obstacle:...
